These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 35873564)
1. Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. Pouliquen DL; Boissard A; Henry C; Coqueret O; Guette C Front Pharmacol; 2022; 13():934534. PubMed ID: 35873564 [TBL] [Abstract][Full Text] [Related]
2. Anti-tumor Effects of Curcuminoids in Glioblastoma Multiforme: An Updated Literature Review. Afshari AR; Jalili-Nik M; Abbasinezhad-Moud F; Javid H; Karimi M; Mollazadeh H; Jamialahmadi T; Sathyapalan T; Sahebkar A Curr Med Chem; 2021; 28(39):8116-8138. PubMed ID: 33176632 [TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis. Drak Alsibai K; Meseure D Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356 [TBL] [Abstract][Full Text] [Related]
4. Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future. Pouliquen DL; Trošelj KG; Anto RJ Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376060 [TBL] [Abstract][Full Text] [Related]
5. [Research progresses in the biosynthesis of curcuminoids]. Wang L; Han X; Wang F; Sun L; Xin F Sheng Wu Gong Cheng Xue Bao; 2021 Feb; 37(2):404-417. PubMed ID: 33645144 [TBL] [Abstract][Full Text] [Related]
6. The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma. Ramundo V; Zanirato G; Aldieri E Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830097 [TBL] [Abstract][Full Text] [Related]
7. Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition. Song W; Mazzieri R; Yang T; Gobe GC Front Immunol; 2017; 8():1106. PubMed ID: 28955335 [TBL] [Abstract][Full Text] [Related]
8. Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue. Ramezani M; Hatamipour M; Sahebkar A J Cell Physiol; 2018 Feb; 233(2):880-887. PubMed ID: 28075008 [TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs and nuclear architecture during epithelial-mesenchymal transition in lung cancer and idiopathic pulmonary fibrosis. Rubio K; Castillo-Negrete R; Barreto G Cell Signal; 2020 Jun; 70():109593. PubMed ID: 32135188 [TBL] [Abstract][Full Text] [Related]
10. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry. Bonavida B; Baritaki S Crit Rev Oncog; 2011; 16(3-4):211-26. PubMed ID: 22248055 [TBL] [Abstract][Full Text] [Related]
11. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition. Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858 [TBL] [Abstract][Full Text] [Related]
12. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Creighton CJ; Gibbons DL; Kurie JM Cancer Manag Res; 2013; 5():187-95. PubMed ID: 23986650 [TBL] [Abstract][Full Text] [Related]
13. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Changtam C; de Koning HP; Ibrahim H; Sajid MS; Gould MK; Suksamrarn A Eur J Med Chem; 2010 Mar; 45(3):941-56. PubMed ID: 20004045 [TBL] [Abstract][Full Text] [Related]
14. The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study. Najafi M; Mortezaee K; Rahimifard M; Farhood B; Haghi-Aminjan H Life Sci; 2020 Sep; 257():118051. PubMed ID: 32634426 [TBL] [Abstract][Full Text] [Related]
15. The Emerging Roles of Exosomes as EMT Regulators in Cancer. Kim H; Lee S; Shin E; Seong KM; Jin YW; Youn H; Youn B Cells; 2020 Apr; 9(4):. PubMed ID: 32252322 [TBL] [Abstract][Full Text] [Related]
16. The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation. Iser IC; Pereira MB; Lenz G; Wink MR Med Res Rev; 2017 Mar; 37(2):271-313. PubMed ID: 27617697 [TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition in gastric cancer. Huang L; Wu RL; Xu AM Am J Transl Res; 2015; 7(11):2141-58. PubMed ID: 26807164 [TBL] [Abstract][Full Text] [Related]
19. A panel of emerging EMT genes identified in malignant mesothelioma. Wu L; Amjad S; Yun H; Mani S; de Perrot M Sci Rep; 2022 Jan; 12(1):1007. PubMed ID: 35046456 [TBL] [Abstract][Full Text] [Related]
20. miR-137 Inhibition of the Invasion, Metastasis, and Epithelial-Mesenchymal Transition of Nasopharyngeal Cancer by Regulating KDM1A. Lu HQ; Wang RK; Wang HR; Zhou GQ; Zhang YS J Oncol; 2021; 2021():6060762. PubMed ID: 34956364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]